Volodymyr Malashnyak
Highly skilled Solution Architect / System Engineer with over 20 years of experience in developing a...
London, London, United Kingdom
*50 free lookup(s) per month.
No credit card required.
Volodymyr Malashnyak’s Email vmalashnyak@nec.com
Social Media
Volodymyr Malashnyak’s Location London, London, United Kingdom
Volodymyr Malashnyak’s Current Industry Nec Europe
Volodymyr Malashnyak’s Prior Industry Ericsson | Lucent Technologies
Not the Volodymyr Malashnyak you were looking for?
Find accurate emails & phone numbers for over 700M professionals.
Work Experience
Nec Europe
Consultant Systems Engineer
2022-02-01 00:00:00 - Present
Ericsson
Strategy & Standardization Expert
2020-01-01 00:00:00 - 2022-02-01 00:00:00
Lucent Technologies
Support Engineer (After-Sales)
2000-05-01 00:00:00 - 2001-05-01 00:00:00Skills
Languages
FAQ About Volodymyr Malashnyak
-
Volodymyr Malashnyak is located at
London, London, United Kingdom -
Volodymyr Malashnyak is a Highly skilled Solution Architect / System Engineer with over 20 years of experience in developing and delivering large scale solutions and applications
-
Volodymyr Malashnyak currently works in the Nec Europe |
-
No Languages Available
-
Volodymyr Malashnyak has prior
experience in the following industries:
Ericsson | Lucent Technologies -
Volodymyr Malashnyak has the following professional experience:
Nec Europe | Ericsson | Lucent Technologies -
You can view Volodymyr Malashnyak’s LinkedIn profile at LinkedIn URL
-
Volodymyr Malashnyak’s work email
addresses are
vmalashnyak@nec.com -
Nec Europe |
People you may be interested in
-
Brendan Foley
-
Marco Kroonwijk
-
Danzel Anerfee Orig
-
Kathryn Biery
-
Victoria Chiou
Functional edible coatings and specialty products for the pharmaceutical, confectionery,...
Passionate IT-professional with 25 years of experience in software development....
Continuous Improvement driven, flexible, and proactively likes to make contributions...
Owner, Mountain View Dental
Head, Clinical Excellence and Innovation, Late Development Oncology at AstraZeneca